Akebia Therapeutics
AKBA
#9606
Rank
โ‚น9.98 B
Marketcap
โ‚น35.97
Share price
-8.71%
Change (1 day)
-74.50%
Change (1 year)

Earnings for Akebia Therapeutics (AKBA)

Earnings in 2026 (TTM): -โ‚น4.05 Billion

According to Akebia Therapeutics's latest financial reports the company's current earnings are โ‚น0.19 Billion. In 2025 the company made an earning of -โ‚น0.35 Billion, an increase over its 2024 earnings that were of -โ‚น6.48 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Akebia Therapeutics from 2013 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚น4.05 Billion1064.4%
2025 -โ‚น0.35 Billion-94.64%
2024 -โ‚น6.48 Billion33.68%
2023 -โ‚น4.85 Billion-45.12%
2022 -โ‚น8.83 Billion-66.55%
2021 -โ‚น26.39 Billion-26.24%
2020 -โ‚น35.78 Billion33.94%
2019 -โ‚น26.71 Billion66.52%
2018 -โ‚น16.04 Billion123.53%
2017 -โ‚น7.18 Billion-43.34%
2016 -โ‚น12.67 Billion123.58%
2015 -โ‚น5.67 Billion63.95%
2014 -โ‚น3.46 Billion181.24%
2013 -โ‚น1.23 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
โ‚น1.746 T-43,455.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚น1.179 T-29,379.76%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Amgen
AMGN
โ‚น1.031 T-25,695.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
-โ‚น14.29 Billion 254.59%๐Ÿ‡บ๐Ÿ‡ธ USA